美團點評(3690.HK)漲超3%再創歷史新高 市值位列港股第16位
格隆匯1月13日丨美團點評(3690.HK)今日大漲,盤中再創歷史新高價113.9港元,現報112.9港元,漲3.01%,暫成交13.13億港元,最新總市值6557.68億港元,僅次於阿里騰訊成為中國互聯網第三大市值公司的同時,也位居港股市場第16位。該股2019年累漲132.12%。2020年迄今為止已累漲超10%。瑞信近日發研報升美團點評目標價至135港元,指盈利透明度改善。報告稱預計美團點評在強勁的訂單量增長、廣告收入貢獻提升等帶動下,收入將繼續增長,因此預期2019年可扭虧為盈賺32.63億元人民幣,並輕微調升今年盈利預測至90.95億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.